common.study.topics.clinical

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease

common.study.values.description

“Stopping Aminosalicylate Therapy in Inactive Crohn's Disease”

The purpose of this study is to assess whether withdrawal of aminosalicylate (5-ASA) is non-inferior to continuation of 5-ASA therapy in Crohn's disease (CD) subjects in remission.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Recruiting patients only common.study.methods.is-healthy-yes

5-ASA Withdrawal

Withdrawal of 5-ASA therapy

participant.views.study.view.additional

participant.views.study.view.scientific-title

Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (STATIC) Study: A Randomized, Open-label, Non-inferiority Trial

common.study.values.clinical-trial-id

NCT03261206

participant.views.study.view.id

nel4le